Learn more →
Back to Expert Scholars
clinical / clinicalHER2+ breast cancer treatment access

Rachel Won

雷切尔·温

MD

🏢BC Cancer(不列颠哥伦比亚省癌症中心)🌐Canada

Medical Oncologist肿瘤内科医师

32
h-index
1
Key Papers
1
Awards
2
Key Contributions

👥Biography 个人简介

Rachel Won at BC Cancer is a breast cancer specialist with expertise in HER2-targeted therapy and global treatment access issues. She has contributed to research on biosimilar trastuzumab implementation and cost-effectiveness of HER2-targeted regimens in different healthcare systems.

Share:

🧪Research Fields 研究领域

HER2-positive breast cancerHER2阳性乳腺癌
treatment access治疗获取
global oncology全球肿瘤学
biosimilars生物类似药
trastuzumab曲妥珠单抗

🎓Key Contributions 主要贡献

Biosimilar Trastuzumab Implementation

Contributed to research on biosimilar trastuzumab safety, efficacy equivalence, and implementation strategies in publicly funded Canadian healthcare systems.

Treatment Access Research

Investigated health equity in HER2+ breast cancer treatment, identifying barriers to access in diverse Canadian populations.

Representative Works 代表性著作

[1]

Biosimilar trastuzumab for HER2-positive breast cancer: real-world outcomes in a population-based cohort

Breast Cancer Research and Treatment (2022)

Real-world biosimilar trastuzumab analysis.

🏆Awards & Recognition 奖项与荣誉

🏆BC Cancer Research Award

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 雷切尔·温 的研究动态

Follow Rachel Won's research updates

留下邮箱,当我们发布与 Rachel Won(BC Cancer)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment